MYH11 Gene Aortic Aneurysm Familial Thoracic Type 4 Genetic Test sale cost 4400 AED
Clopidogrel CYP2C19 Genotype Test sale cost 8420 AED Clopidogrel CYP2C19 Genotype Test Cost 9,360 د.إ Original price was: 9,360 د.إ.8,420 د.إCurrent price is: 8,420 د.إ.
HTRA1 Gene CARASIL Genetic Test sale cost 4400 AED HTRA1 Gene CARASIL Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

MYH11 Gene Aortic Aneurysm Familial Thoracic Type 4 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYH11 Gene Aortic Aneurysm Familial Thoracic Type 4 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the MYH11 gene, which are associated with a predisposition to familial thoracic aortic aneurysms. This type of aortic aneurysm is a serious condition where the wall of the thoracic section of the aorta, the major artery carrying blood out of the heart, weakens and can lead to life-threatening complications if not managed properly. The test is particularly crucial for individuals with a family history of this condition, as it can provide vital information for early detection, preventive measures, and tailored treatment strategies.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the MYH11 gene that have been linked to the development of thoracic aortic aneurysms. The process is designed to be as non-invasive and straightforward as possible, with a focus on providing accurate and reliable results.

The cost of the MYH11 Gene Aortic Aneurysm Familial Thoracic Type 4 Genetic Test is 4400 AED. While the price may seem significant, the value of the information it provides cannot be overstated for those at risk. Early detection and intervention can significantly improve the quality of life and survival rates for individuals predisposed to this condition. This test represents an important step in proactive health management and genetic counseling for affected families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MYH11 Gene Aortic Aneurysm Familial Thoracic Type 4 Genetic Test

Welcome to DNA Labs UAE, where we offer the MYH11 Gene Aortic Aneurysm Familial Thoracic Type 4 Genetic Test. This test helps diagnose individuals with FTAAD4 or determine their risk of developing the condition.

Test Details

The MYH11 gene is associated with a condition called familial thoracic aortic aneurysm type 4 (FTAAD4). This genetic test uses next-generation sequencing (NGS) technology to analyze the MYH11 gene for any disease-causing mutations or variants. Familial thoracic aortic aneurysm (FTAAD) refers to a group of genetic disorders that cause the aorta, the main blood vessel that carries blood from the heart to the rest of the body, to become weakened and enlarged. FTAAD4 specifically refers to a form of FTAAD caused by mutations in the MYH11 gene.

NGS genetic testing allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of genetic variations associated with aortic aneurysms. By identifying specific mutations or variants in the MYH11 gene, this test can help diagnose individuals with FTAAD4 or determine their risk of developing the condition.

Genetic testing for FTAAD4 can be particularly useful for individuals with a family history of aortic aneurysms, as it can help identify at-risk family members who may benefit from regular monitoring or preventive interventions. It can also aid in genetic counseling and family planning decisions.

It’s important to note that the MYH11 gene is just one of many genes associated with FTAAD, and there may be other genetic causes for the condition. Therefore, a negative test result for MYH11 mutations does not rule out the possibility of FTAAD or other genetic causes.

Test Components and Price

  • Test Name: MYH11 Gene Aortic Aneurysm Familial Thoracic Type 4 Genetic Test
  • Components: NGS Technology
  • Price: 4400.0 AED

Sample Condition and Report Delivery

  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks

Test Type and Doctor

  • Test Type: Vascular Diseases
  • Doctor: General Physician

Test Department and Pre Test Information

  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for MYH11 Gene Aortic Aneurysm, familial thoracic type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYH11 Gene Aortic Aneurysm, familial thoracic type 4 NGS Genetic DNA Test gene MYH11

If you or someone you know is considering genetic testing for FTAAD4, it is recommended to consult with a healthcare professional or a genetic counselor who can provide guidance and support throughout the testing process.

Test Name MYH11 Gene Aortic aneurysm familial thoracic type 4 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Vascular Diseases
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MYH11 Gene Aortic aneurysm, familial thoracic type 4 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYH11 Gene Aortic aneurysm, familial thoracic type 4 NGS Genetic DNA Test gene MYH11
Test Details

The MYH11 gene is associated with a condition called familial thoracic aortic aneurysm type 4 (FTAAD4). This genetic test uses next-generation sequencing (NGS) technology to analyze the MYH11 gene for any disease-causing mutations or variants.

Familial thoracic aortic aneurysm (FTAAD) refers to a group of genetic disorders that cause the aorta, the main blood vessel that carries blood from the heart to the rest of the body, to become weakened and enlarged. FTAAD4 specifically refers to a form of FTAAD caused by mutations in the MYH11 gene.

NGS genetic testing allows for the simultaneous analysis of multiple genes, providing a comprehensive assessment of genetic variations associated with aortic aneurysms. By identifying specific mutations or variants in the MYH11 gene, this test can help diagnose individuals with FTAAD4 or determine their risk of developing the condition.

Genetic testing for FTAAD4 can be particularly useful for individuals with a family history of aortic aneurysms, as it can help identify at-risk family members who may benefit from regular monitoring or preventive interventions. It can also aid in genetic counseling and family planning decisions.

It’s important to note that the MYH11 gene is just one of many genes associated with FTAAD, and there may be other genetic causes for the condition. Therefore, a negative test result for MYH11 mutations does not rule out the possibility of FTAAD or other genetic causes.

If you or someone you know is considering genetic testing for FTAAD4, it is recommended to consult with a healthcare professional or a genetic counselor who can provide guidance and support throughout the testing process.

SKU: TEST-3498 Category:

Related products